Medical Device News Magazine

Aditya Khosla PhD Joins Iterative Scopes as Chief Technology Officer

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Aditya Khosla  PhD has joined the Iterative Scopes leadership team as Chief Technology Officer, and a member of the board of directors.

“We are thrilled to welcome Dr. Khosla to the Iterative Scopes team,” says Jonathan Ng, MBBS, founder and CEO of Iterative Scopes. “Aditya brings a dedicated expertise in machine learning and improving patient outcomes with AI-powered healthcare technologies.”

In his role as CTO, Dr. Khosla will lead Iterative Scopes’ machine learning, product management, and software engineering teams.

Prior to joining Iterative Scopes, Dr. Khosla was the co-founder and CTO of PathAI, where he led the engineering and IT, machine learning, product, and recruiting teams. Dr. Khosla co-founded PathAI in 2016. The company has grown to become the leading provider of AI-powered research tools and services for pathology. During his tenure as CTO and co-founder, PathAI raised over $250M from leading investors, and now employs over 700 people.

“I’m excited to join Iterative Scopes as it makes significant inroads toward eliminating the disparities in care for the treatment of GI diseases,” says Dr. Khosla. “Its application of real-time, computer-vision-based technologies for precision medicine has the potential to benefit millions of patients at their point of care. I’m looking forward to applying my background and skills to drive discovery and predictive diagnostics that support the Iterative Scopes mission.”

Dr. Khosla completed his PhD in machine learning and computer vision at MIT. He has published over 60 papers and patents in the fields of deep learning, computer vision, and computational pathology. According to Google Scholar, he is one of the top 100 most cited researchers in computer vision, with his work receiving over 55,000 citations.

“I’ve gotten to know Aditya over the past four years at MIT where I had the privilege of attending his lectures, as an advisor to the company and mentor to myself, and now coming full circle as a teammate at Iterative Scopes,” says Dr. Ng. “I am incredibly excited for Aditya to bring his scientific leadership and operational expertise to Iterative Scopes to unlock a new generation of AI tools in gastroenterology.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”